Elissa Kalver, 38, was diagnosed with incurable HER2-positive metastatic breast cancer at 34. Despite a grim initial prognosis (80% chance of death within five years), she's thrived for four years thanks to aggressive treatment, including chemotherapy and clinical trials. While the cancer has spread to her brain and other areas, targeted therapies have significantly reduced tumors. Kalver emphasizes prioritizing quality of life, celebrating milestones, and advocating for other cancer patients through her non-profit 'We Got This'. Medical advances offer improved outcomes for those with this aggressive cancer subtype.

Prepared by Olivia Bennett and reviewed by editorial team.